Endometrial Stromal Sarcoma: Objective Response to Letrozole
- 1 August 2001
- journal article
- case report
- Published by Elsevier in Gynecologic Oncology
- Vol. 82 (2) , 384-388
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Letrozole, a new oral aromatase inhibitor for advanced breast cancer: double-blind randomized trial showing a dose effect and improved efficacy and tolerability compared with megestrol acetate.Journal of Clinical Oncology, 1998
- Steroid Hormone Receptors in Endometrial Stromal Sarcomas: A Biochemical and Immunohistochemical StudyAmerican Journal of Clinical Pathology, 1992
- Retrospective analysis of 318 cases of uterine sarcomaEuropean Journal of Cancer and Clinical Oncology, 1991
- Uterine sarcoma: Steroid receptors and response to hormonal therapyGynecologic Oncology, 1990
- Endometrial stromal sarcoma: A clinicopathologic study of 11 cases with determination of estrogen and progestin receptor levels in three tumorsGynecologic Oncology, 1987
- Endolymphatic stromal myosis: A case with positive estrogen and progesterone receptors and good response to progestinsGynecologic Oncology, 1985
- Endolymphatic stromal myosis. Surgical and hormonal treatment of extensive abdominal recurrence 20 years after hysterectomyCancer, 1982